Diabetes Insipidus - 29 Studies Found
| Completed |
: A PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) : Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) : 2013-12-09 : Drug: tolvaptan Subjects will receive a single dose of 3.75, 7.5 or 15 mg of tolvaptan on study Day 1 |
| Not yet recruiting |
: Atorvastatin for the Treatment of Lithium-Induced Nephrogenic Diabetes Insipidus : Bipolar Disorder : 2016-11-15 :
|
| Completed |
: Effect of Statin Treatment on Urinary AQP2 (uAQP2/01) :
: 2015-08-10 |
| Terminated |
: Oxytocin and Arginine Vasopressin in Pain Relief : Placebo Analgesia : 2011-04-01 |
| Recruiting |
: A Multicenter Trial to Investigate the Efficacy and Safety of Tolvaptan in Patients With Hyponatremia in SIADH : Syndrome of Inappropriate Antidiuretic Hormone Secretion : 2017-02-07 : Drug: Tolvaptan Oral Tablet Tolvaptan tablets at 7.5, 15, 30 (one tablet each), or 60 mg (two 30 mg tabl |
| Completed |
: Regulation of Arginine-vasopressin (AVP) :
: 2015-11-04 : Other: Procedural All subjects receive intravenous hypertonic saline and serial blood samples are drawn |
| Completed |
: 1-deamino 8-d-arginine Vasopressin (DDAVP) in Percutaneous Ultrasound-guided Renal Biopsy : Kidney Failure : 2008-09-05 :
|
| Completed |
: The Effects of Estradiol and Progesterone on Arginine Vasopressin Regulation and Serum Sodium Concentration : Exercise Induced Hyponatremia : 2008-01-02 :
|
| Recruiting |
: AVERT Shock: Arginine Vasopressin During the Early Resuscitation of Traumatic Shock : Traumatic Shock : 2012-06-01 : Drug: Vasopressin After receiving greater than 6 units of blood product within the first 12 hours of adm |
| Completed |
: Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion :
: 2005-12-12 : Drug: SR121463B |